Enclomiphene | 120 x 6 mg

SAFETY DATA SHEET

Enclomifene, also known as Enclomiphene, is the (E)-enantiomer of clomiphene citrate, a selective estrogen receptor modulator (SERM) specifically developed to stimulate endogenous T-production in cases of secondary hypogonadism. Unlike traditional T-replacement therapies, which suppress the hypothalamic-pituitary-gonadal (HPG) axis, it works by blocking estrogen receptors in the hypothalamus.

Key findings from preclinical and clinical studies indicate that enclomiphene may:

• Enhance mitochondrial biogenesis and oxidative metabolism in skeletal muscle tissue
• Increase total energy expenditure and attenuate adipose accumulation under sedentary conditions
• Improve exercise tolerance and endurance-related parameters in animal models, independent of physical training
• Suppress hepatic lipogenesis and reduce plasma lipid levels, including cholesterol and triglycerides
• Attenuate pro-inflammatory cytokine expression and modulate innate immune signaling pathways, with implications for autoimmune and metabolic disease research
• Alter the expression of circadian clock genes, affecting temporal regulation of metabolic and behavioral rhythms

⚠ Important Note: This product is supplied strictly for laboratory research use only. It is not approved for human consumption or therapeutic use. Not intended to diagnose, treat, cure, or prevent any disease.